A Bioequivalence Study Between Telmione Plus 80/12.5mg and Micardis Plus 80/12.5 mg in Healthy Adult Volunteers
Clinical trial NCT05040880 · COMPLETED
Trial details
- NCT number
- NCT05040880
- Sponsor
- HK inno.N Corporation
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-08
- Primary completion
- 2021-10-31
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.